This is a simplistic view. After the molecule was discovered, the patent certainly lowers the supply, but if the patent is what enables the molecule to be discovered in the first place, then it actually increases the supply.
Of course, whether the claim holds is questionable, but it's not like these drugs where flowing from the trees until the bad government came and limited it.
As for the taxes, I don't know the Indian patent office, but the US counterpart makes money.
Or to put it in concert fashion, should a farmer sacrifice a family member to a sickness today, just so he might be able in 20+ years buy a generic version when the price has gone down? If put to a vote, would the majorly of the citizen inside a country vote to vow never allow anyone die just because they are too poor to pay the medicine, or do they rather want the chance of increased new medicines which only a small minority can afford in the next 20+ years?
What would the democratic vote say? My bet would be on the living and not on the patents.
http://thelastpsychiatrist.com/2005/10/if_france_gets_its_wa...
And getting mad at Novartis in this case for "evergreening" also isn't entirely fair, because up until 2003/5 India was the wild west when it came to drugs, and thus Novartis couldn't really sell it there anyway. If India had product patents when Gleevec was invented in 1995, maybe they would be on course to have the generic soon. Instead, the rest of the world is subsidizing cheap drugs for India. We invent, we pay, they benefit.
Of course, evergreening is an extra evil in itself, and lets not forget that pharma also get a extra special monopoly after the patent has expired just for doing drug trials.
I wonder what the majority of the Indian people would prefer. What percentage of citizens of the Republic of India can actually afford the products of companies like Novartis AG when they demand patent licenses, and how much taxes would be free up by abolishing the patent office and patent enforcement?